Christopher Raspin, MSc
Christopher is a Senior Health Economist. He joined Symmetron following the completion of the Health Economics MSc at the University of York where he gained exposure to the different methods for health economic evaluation and health policy evaluation. His interest currently lies in quantitative and statistical analysis having enjoyed and excelled in econometric analysis throughout his academic career. His disease areas of interest include oncology and mental health. He has previously worked as an intern as part of the Health and Value team at Pfizer where he worked on validating a standardised crude economic model and also has experience as a market analyst in the recruitment industry.